I-Kuan Wang1,2,3, Te-Chun Shen4, Chih-Hsin Muo5, Tzung-Hai Yen6,7, Fung-Chang Sung5,8. 1. Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan. 2. Department of Internal Medicine, College of Medicine, China Medical University, Taichung, Taiwan. 3. Division of Nephrology, China Medical University Hospital, Taichung, Taiwan. 4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan. 5. Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan. 6. Division of Nephrology, Chang Gung Memorial Hospital, Taipei, Taiwan. 7. Chang Gung University College of Medicine, Taoyuan, Taiwan. 8. Department of Health Services Administration, College of Public Health, China Medical University, Taichung, Taiwan.
Abstract
BACKGROUND: This study compared the pulmonary embolism (PE) risks between Asian dialysis patients and a comparison cohort without clinical kidney disease. METHODS: From the National Health Insurance claims data of Taiwan, we identified 106 231 newly diagnosed end-stage renal disease patients undergoing dialysis in 1998-2010 and randomly selected 106 231 comparison subjects, frequency matched by age, sex and the index year. We further selected 7430 peritoneal dialysis (PD) patients and 7340 propensity score-matched hemodialysis (HD) patients. Incidence rates and hazard ratios (HRs) of PE and odds ratio (OR) of subsequent 30-day deaths from PE were evaluated among study cohorts by the end of 2011. RESULTS: The overall incident PE was nearly 3-fold greater in dialysis patients than in the comparison cohort (0.92 versus 0.33 per 1000 person-years), with an adjusted HR of 2.02 [95% confidence interval (CI) = 1.63-2.50]. The PE incidence was greater in the propensity score-matched HD patients, than in PD patients with an adjusted HR of 2.30 (95% CI = 1.23-4.29). There was a greater PE risk for central venous catheter users than non-users among HD patients (1.83 versus 0.75 per 1000 person-years). The 30-day mortality from PE was higher in dialysis patients than in the comparison cohort (16.5 versus 9.77%) with an adjusted OR of 2.56 (95% CI = 1.32-4.95). CONCLUSIONS: Dialysis patients are at a nearly 2-fold increased hazard of developing PE and are at greater risk of fatality from PE compared with those without clinical kidney disease. This study also shows a higher PE risk in HD patients than in PD patients.
BACKGROUND: This study compared the pulmonary embolism (PE) risks between Asian dialysis patients and a comparison cohort without clinical kidney disease. METHODS: From the National Health Insurance claims data of Taiwan, we identified 106 231 newly diagnosed end-stage renal disease patients undergoing dialysis in 1998-2010 and randomly selected 106 231 comparison subjects, frequency matched by age, sex and the index year. We further selected 7430 peritoneal dialysis (PD) patients and 7340 propensity score-matched hemodialysis (HD) patients. Incidence rates and hazard ratios (HRs) of PE and odds ratio (OR) of subsequent 30-day deaths from PE were evaluated among study cohorts by the end of 2011. RESULTS: The overall incident PE was nearly 3-fold greater in dialysis patients than in the comparison cohort (0.92 versus 0.33 per 1000 person-years), with an adjusted HR of 2.02 [95% confidence interval (CI) = 1.63-2.50]. The PE incidence was greater in the propensity score-matched HD patients, than in PD patients with an adjusted HR of 2.30 (95% CI = 1.23-4.29). There was a greater PE risk for central venous catheter users than non-users among HD patients (1.83 versus 0.75 per 1000 person-years). The 30-day mortality from PE was higher in dialysis patients than in the comparison cohort (16.5 versus 9.77%) with an adjusted OR of 2.56 (95% CI = 1.32-4.95). CONCLUSIONS: Dialysis patients are at a nearly 2-fold increased hazard of developing PE and are at greater risk of fatality from PE compared with those without clinical kidney disease. This study also shows a higher PE risk in HD patients than in PD patients.
Authors: Anja Gäckler; Hana Rohn; Ton Lisman; Tamas Benkö; Oliver Witzke; Andreas Kribben; Fuat H Saner Journal: PLoS One Date: 2019-02-20 Impact factor: 3.240
Authors: Melissa C Caughey; Randal K Detwiler; Joseph A Sivak; Lisa J Rose-Jones; Abhijit V Kshirsagar; Alan L Hinderliter Journal: Transplantation Date: 2020-10 Impact factor: 5.385
Authors: Gertrude J Nieuwenhuijs-Moeke; Tamar A J van den Berg; Stephan J L Bakker; Marius C van den Heuvel; Michel M R F Struys; Ton Lisman; Robert A Pol Journal: PLoS One Date: 2018-07-16 Impact factor: 3.240
Authors: Amir Shabaka; Enrique Gruss; Eugenia Landaluce-Triska; Eduardo Gallego-Valcarce; Clara Cases-Corona; Javier Ocaña; Ana Tato-Ribera; Katia Lopez-Revuelta; Karina R Furaz-Czerpak; Gema Fernández-Juárez Journal: Hemodial Int Date: 2021-05-31 Impact factor: 1.543